The Same Launch Issue, in Three Voices

"It's Just Aging" Was Never a Good Enough Answer

The first issue of SmartStrongAlive, and what I'm trying to build here.

Here's a visit a lot of women will recognize.

You go in because you're tired in a way that sleep doesn't fix, your memory has gotten slippery, you've put on weight around the middle that won't budge no matter what used to work, and your mood has gone flat. They run a panel. A week later someone tells you the labs are normal. Maybe they offer an antidepressant. Maybe they say it's stress, or perimenopause, or just your age, and that's the end of the appointment. You leave with a prescription or a shrug, and no real explanation for why your body stopped feeling like yours.

I've had versions of that visit. So has nearly every woman I know past 45.

What "aging" leaves out

"Aging" tells you roughly when something is happening. It doesn't tell you what, or why.

A more useful answer names the mechanism. Estradiol falling, and what that does to sleep, mood, bone, and the brain. Insulin resistance creeping up years before it shows on a standard panel. Muscle quietly disappearing after 40, on the order of 3 to 8% a decade, unless you work to keep it. Testosterone declining and taking a chunk of motivation with it. Each of those is measurable. Most are modifiable. None of them are captured by the word "aging."

And to be fair to the clinician, this usually isn't carelessness. The panel really did come back unremarkable, fifteen minutes isn't enough to chase a dozen overlapping systems, and medicine has been burned before by running ahead of its evidence. The trouble is that "normal labs" and "nothing is wrong" are not the same sentence, and the appointment tends to end as if they were. I understand the constraint. I just don't think it should be the last word, and it doesn't have to be.

"Aging" tells you when something is happening. It never tells you what, or why.

Who's writing this

Annette Thompson, founder of SmartStrongAlive

I'm Annette. I'm 57. I'm not a doctor, and I won't write like one or borrow a white coat that isn't mine.

What I have is a science background, a stubborn streak, and about thirty years of reading primary research because I have trouble leaving a question alone once it gets hold of me. I started adoption.com in 1995 and taught myself to build it. I ran orphanages in Ethiopia, Kenya, and Haiti. I adopted seven children. I've spent most of my life pulling complicated problems apart to see how they actually work, and the state of women's health information is one of the messier ones I've come across.

So I read the studies myself. I look at how they were designed, who was actually in them, what they measured, and how large the effect really was. Then I write up what I find in plain language. None of this is a substitute for your own doctor. The point is to walk into that office better informed, with sharper questions and a sense of what the evidence does and doesn't support.

Why I want to get this right

I have a particular reason to care about the brain-health research. I carry two copies of the APOE4 gene, the E4/E4 pairing that comes with the highest genetic risk for Alzheimer's. My mother has the disease now. When I read the work on estrogen, metabolic health, and cognition, I'm reading it as someone who has a real stake in whether any of it holds up.

What this publication covers

SmartStrongAlive is a women's health and longevity publication. Menopause is usually the first door women walk through, but the scope is wider:

• Hormones, including the HRT and testosterone research most of us were never told existed
• Brain health and dementia risk, especially when it runs in the family
• Metabolic health: blood sugar, insulin, and how much of the rest sits on top of it
• Strength and muscle, and the exercise research that was mostly done on men
• Lab work: which numbers are worth asking for, and what they actually mean
• Genetics, and what your DNA does and doesn't decide

A lot of this got buried for a long time. In 2002, the Women's Health Initiative stopped its estrogen-plus-progestin arm early, about 16,000 women, the coverage was alarming, and a generation of doctors backed away from prescribing hormones at all. The trial was real. What it actually showed was narrower than how it was reported: the women were on average more than a decade past menopause, on one specific oral formulation. We're still sorting out the fallout twenty years later. That sorting-out is a good deal of what I'll write about.

How I'll handle the evidence

Every claim I make will point to a source you can check: PubMed, peer-reviewed journals, the paper itself. When the evidence is strong, I'll say so. When it's thin, mixed, or based on a study that doesn't really apply to you, I'll say that too, instead of rounding a maybe up to a yes. I would rather tell you something is uncertain than hand you false confidence.

I'm also not building this to sell you supplements, and I won't talk down to you. You can handle a real explanation, including the parts that don't resolve cleanly.

What to expect, and where to start

I publish once or twice a week. Some pieces are deep dives with full citations. Others are short and practical: one lab value, or one question worth raising at your next appointment.

A few that are coming soon: why an antidepressant couldn't touch a particular kind of flatness, and what finally did; the hormone almost no woman gets offered; and what the 2002 hormone study actually said, set next to what everyone heard.

If that's the kind of thing you've been looking for, you can subscribe below. It's free. And if a specific question is what brought you here, reply and tell me what it is. I read everything, and it shapes what I write next.

Annette
SmartStrongAlive | Because "it's just aging" was never a good enough answer.

What "It's Just Aging" Misses: Estradiol, Muscle, and the Aging Brain

The first issue of SmartStrongAlive.

Here's something that rarely fits into a fifteen-minute appointment. When estradiol declines across the menopausal transition, it isn't only a reproductive change. Estradiol helps regulate glucose metabolism in the brain, it supports mitochondrial function, and it influences bone remodeling and how blood vessels dilate. So when a woman in her late forties reports fatigue, brain fog, and a loss of strength, and her standard panel comes back "normal," that panel isn't measuring most of what actually shifted.

Take muscle. After about age 40, most people lose roughly 3 to 8% of their muscle mass per decade, and the loss accelerates later in life. That's sarcopenia, and in observational data it's strongly associated with all-cause mortality, independent of other risk factors. It's measurable. It's also modifiable: resistance training and adequate protein are two of the more robust interventions we have. And it almost never comes up when fatigue gets labeled "just age."

The problem with "aging" as an answer

Aging tells you roughly when something is happening. It doesn't tell you the mechanism. A more useful answer names what changed: falling estradiol, rising insulin resistance, declining mitochondrial density, a drop in VO2 max. Each of those has a biomarker you can actually measure, and most of them respond to intervention.

Aging tells you when. The mechanism tells you what to do about it.

Who's writing this

Annette Thompson, founder of SmartStrongAlive

I'm Annette. I want to be clear up front: I'm not a physician, and I'm not going to write like one. What I do is read the primary literature, the actual papers, and pay attention to study design. Was this an observational study, where we can only say two things are associated? Or a randomized controlled trial, where we can start to talk about causation? Who was in the cohort, what was the effect size, and does it generalize to the woman reading it?

Why I read the brain literature so closely

I have a specific reason. I carry two copies of the APOE4 allele, the E4/E4 genotype. In genetic-association data, that's linked to roughly an eight to twelvefold higher lifetime risk of Alzheimer's compared with the common E3/E3 genotype, though the exact figure varies by population and by sex. My mother has the disease. So when I read Lisa Mosconi's PET imaging work on declining glucose metabolism in the menopausal brain, or the literature on estradiol and neuronal energetics, I'm reading it as someone with a real stake in whether the mechanism holds up.

What this publication covers

SmartStrongAlive is a women's health and longevity publication. Menopause is usually the first entry point, but the scope is broader, and I try to keep each topic anchored to something measurable:

• Hormones: the estradiol, progesterone, and testosterone research, and what the trials actually show
• Brain health and dementia risk, especially APOE genotype and the estrogen-cognition literature
• Metabolic health: glucose, insulin, and the markers that track them
• Strength, muscle, and VO2 max, three of the better predictors of healthspan
• Lab work: which biomarkers are worth measuring, and what the numbers mean
• Genetics: what your genotype shifts in probability, and what it doesn't determine

How I'll handle the evidence

Here's the standard I hold myself to. Every claim points to a source you can check. I'll tell you whether a finding is observational, where we can only establish an association, or an intervention trial, where we can begin to talk about cause. I'll flag when something has only been shown in animal models and hasn't been replicated in humans. And I'll give you the actual number, the percentage, the dose, the comparison group, because without the number you can't evaluate the claim.

The clearest example of why this matters is the Women's Health Initiative. In 2002, the estrogen-plus-progestin arm, about 16,000 women, was stopped early, the coverage was alarming, and a generation of clinicians stopped prescribing hormones. But the women in that arm were on average more than a decade past menopause, on one specific oral formulation. The "timing hypothesis," the idea that the risk-benefit balance depends heavily on when therapy starts relative to menopause, came out of reanalyzing that data, and it's still being worked out. That kind of nuance gets flattened into "hormones are dangerous," and untangling it is a lot of what I'll write about.

Where to start

None of this is meant to alarm you. The through-line across almost every topic here is the same: there's a mechanism, there's a biomarker that tracks it, and there's usually something you can do that moves the number, whether that's strength training, raising VO2 max, the right labs, or a better-informed conversation with a clinician who'll actually have it.

I publish once or twice a week. If that's what you've been looking for, you can subscribe below. And if a specific question brought you here, reply and tell me. It shapes what I look into next.

Annette
SmartStrongAlive | Because "it's just aging" was never a good enough answer.

"It's Just Aging" Was Never a Good Enough Answer

The first issue of SmartStrongAlive, and what I'm trying to build here.

Here's a visit a lot of women will recognize.

You go in because you're tired in a way that sleep doesn't fix, your memory has gotten slippery, you've put on weight around the middle that won't budge no matter what used to work, and your mood has gone flat. They run a panel. A week later someone tells you the labs are normal. Maybe they offer an antidepressant. Maybe they say it's stress, or perimenopause, or just your age, and that's the end of the appointment. You leave with a prescription or a shrug, and no real explanation for why your body stopped feeling like yours.

I've had versions of that visit. So has nearly every woman I know past 45.

What "aging" leaves out

"Aging" tells you roughly when something is happening. It doesn't tell you what, or why.

A more useful answer names the mechanism. Estradiol falling, and what that does to sleep, mood, bone, and the brain. Insulin resistance creeping up years before it shows on a standard panel. Muscle quietly disappearing after 40, on the order of 3 to 8% a decade, unless you work to keep it. Testosterone declining and taking a chunk of motivation with it. Each of those is measurable. Most are modifiable. None of them are captured by the word "aging."

And to be fair to the clinician, this usually isn't carelessness. The panel really did come back unremarkable, fifteen minutes isn't enough to chase a dozen overlapping systems, and medicine has been burned before by running ahead of its evidence. The trouble is that "normal labs" and "nothing is wrong" are not the same sentence, and the appointment tends to end as if they were. I understand the constraint. I just don't think it should be the last word, and it doesn't have to be.

"Aging" tells you when something is happening. It never tells you what, or why.

Who's writing this

Annette Thompson, founder of SmartStrongAlive

I'm Annette. I'm 57. I'm not a doctor, and I won't write like one or borrow a white coat that isn't mine.

What I have is a science background, a stubborn streak, and about thirty years of reading primary research because I have trouble leaving a question alone once it gets hold of me. I started adoption.com in 1995 and taught myself to build it. I ran orphanages in Ethiopia, Kenya, and Haiti. I adopted seven children. I've spent most of my life pulling complicated problems apart to see how they actually work, and the state of women's health information is one of the messier ones I've come across.

So I read the studies myself. I look at how they were designed, who was actually in them, what they measured, and how large the effect really was. Then I write up what I find in plain language. None of this is a substitute for your own doctor. The point is to walk into that office better informed, with sharper questions and a sense of what the evidence does and doesn't support.

Why I want to get this right

I have a particular reason to care about the brain-health research. I carry two copies of the APOE4 gene, the E4/E4 pairing that comes with the highest genetic risk for Alzheimer's. My mother has the disease now. When I read the work on estrogen, metabolic health, and cognition, I'm reading it as someone who has a real stake in whether any of it holds up.

What this publication covers

SmartStrongAlive is a women's health and longevity publication. Menopause is usually the first door women walk through, but the scope is wider:

• Hormones, including the HRT and testosterone research most of us were never told existed
• Brain health and dementia risk, especially when it runs in the family
• Metabolic health: blood sugar, insulin, and how much of the rest sits on top of it
• Strength and muscle, and the exercise research that was mostly done on men
• Lab work: which numbers are worth asking for, and what they actually mean
• Genetics, and what your DNA does and doesn't decide

A lot of this got buried for a long time. In 2002, the Women's Health Initiative stopped its estrogen-plus-progestin arm early, about 16,000 women, the coverage was alarming, and a generation of doctors backed away from prescribing hormones at all. The trial was real. What it actually showed was narrower than how it was reported: the women were on average more than a decade past menopause, on one specific oral formulation. We're still sorting out the fallout twenty years later. That sorting-out is a good deal of what I'll write about.

How I'll handle the evidence

Every claim I make will point to a source you can check: PubMed, peer-reviewed journals, the paper itself. When the evidence is strong, I'll say so. When it's thin, mixed, or based on a study that doesn't really apply to you, I'll say that too, instead of rounding a maybe up to a yes. I would rather tell you something is uncertain than hand you false confidence.

I'm also not building this to sell you supplements, and I won't talk down to you. You can handle a real explanation, including the parts that don't resolve cleanly.

What to expect, and where to start

I publish once or twice a week. Some pieces are deep dives with full citations. Others are short and practical: one lab value, or one question worth raising at your next appointment.

A few that are coming soon: why an antidepressant couldn't touch a particular kind of flatness, and what finally did; the hormone almost no woman gets offered; and what the 2002 hormone study actually said, set next to what everyone heard.

If that's the kind of thing you've been looking for, you can subscribe below. It's free. And if a specific question is what brought you here, reply and tell me what it is. I read everything, and it shapes what I write next.

Annette
SmartStrongAlive | Because "it's just aging" was never a good enough answer.

Your Labs Are "Normal." So Why Don't You Feel Like Yourself?

The first issue of SmartStrongAlive.

Here's something that shouldn't be true, and is. A woman can sit in a doctor's office, describe months of exhaustion, brain fog, flattened mood, and disappearing strength, get a full panel back marked "normal," and walk out with an antidepressant and no explanation. Her labs are fine. She is not fine. Both of those things are true at the same time, and almost nobody stops to ask how.

So let me tell you where we're going. First, what "aging" is actually hiding. Then the part where the skeptics have a point. Then why I, personally, cannot look away from this. And finally, what to do with all of it. This is the first issue of SmartStrongAlive, and that arc is the whole publication in miniature.

What "aging" is hiding

"Aging" is not a mechanism. I think that's the core problem. It tells you when something is happening and almost nothing about what. And the "what" is usually very specific. Estradiol falls, and with it goes a chunk of how the brain handles glucose, how bone remodels, how blood vessels relax. Insulin resistance creeps up years before a fasting glucose flags it. Muscle quietly leaves after 40, on the order of 3 to 8% per decade, unless you actively work to keep it. Each of those is a mechanism. Each has a biomarker. Most of them move when you do something.

That one word is doing a lot of hiding.

What the critics say

Now, here's the part most newsletters skip. The clinician who says "it's your age" is not always wrong, and not always lazy. The panel really did come back unremarkable. Fifteen minutes really isn't enough to chase a dozen overlapping systems. And medicine has been burned before by getting ahead of its evidence, so I want to be fair to that. The problem isn't that doctors are careless. It's that "normal labs" and "nothing is wrong" are not the same statement, and the appointment usually ends as if they were.

Take the study that shaped two decades. In 2002, the Women's Health Initiative stopped the estrogen-plus-progestin arm early, roughly 16,000 women, and the headlines were brutal. Here's the context that got lost. The women in that arm were, on average, more than a decade past menopause, on one specific oral formulation. That's a real result. It's also a narrow one. The "timing hypothesis," the idea that when you start hormones relative to menopause changes the whole risk-benefit math, came out of re-reading that same data, and it's still being argued. Actually, that's my favorite kind of story: same data, better question.

Why I can't look away

Annette Thompson, founder of SmartStrongAlive

And here's where it stops being abstract for me. I'm Annette. I carry two copies of the APOE4 gene, the E4/E4 version, which carries the highest genetic risk there is for Alzheimer's. My mother has the disease. So when I read the work on estrogen and the menopausal brain, I'm not reading it as a spectator. I read the actual papers, I look at the design, and I try very hard not to want a particular answer. I'm not a doctor, and I'll never write like one. What I am is someone with a real stake and a long habit of reading primary research.

What to do with it

So what is this publication actually for? Information, not prescriptions. Every claim I make will name its source, and I'll tell you how good that source is, whether it's an observational signal or a real trial, because you should know how much weight to put on it. I'll cover hormones, brain health, metabolic health, strength, the labs worth asking for, and what your genes do and don't decide. I think you can handle the nuance. I think you'd rather have it.

And none of this is here to scare you. The through-line is the opposite: there's a mechanism, there's a number that tracks it, and there's usually something you can do that moves it.

I publish once or twice a week. If that's what you've been looking for, the subscribe button is below, and if a specific question brought you here, hit reply and tell me. I'm not telling you what to do. I'm trying to give you what you need to make an informed choice.

Stay curious.
Annette
SmartStrongAlive | Because "it's just aging" was never a good enough answer.